InvestorsHub Logo
Followers 5
Posts 333
Boards Moderated 0
Alias Born 02/20/2018

Re: Saltz post# 40019

Friday, 04/19/2019 10:30:11 AM

Friday, April 19, 2019 10:30:11 AM

Post# of 233476
Hehe, I totally agree with you! If GILD waits any longer they will be stuck with a horrible deal due to CYDY doing all the leg work. Once they are green lighted for Mono and or Cancer, it is going to cost them a lot more money to be a partner, because at that point, they will not be able to afford the company, even with the billions that they have. If this works with cancer, gvhd, hiv, and other autoimmune diseases, Cytodyn will become a key drug maker for the entire world. We will be out of the billion hemisphere and it will then cost Trillions to buy it out. The best GILD will do is a license deal, and even then, it should be a very small cut for them since they failed to help progress the drug at any stage. Tick tock...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News